icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
dwPmb03Xa1YpZ95b
Listen
